Stada Strikes Deal To Launch ViruProtect In Nordics
Stada to launch innovative common cold spray ViruProtect in four Nordic markets in 2021 after striking a new agreement with Sweden's Enzymatica.
You may also be interested in...
Latest EU business news: HRA Pharma strikes distribution deal with Vemedia for Spain; and Enzymatica increases ColdZyme production to meet growing demand.
Germany's Stada has expanded its deal with Enymatica to take the latter's ViruProtect common cold brand into Russia, the CIS and beyond.
A recent in vitro study shows that Enzymatica's ColdZyme throat spray – the basis for Stada's ViruProtect in Belgium and Austria – could offer a protective barrier against harmful viruses such as SARS-CoV-2.